Virtual Reality Instructional Design in Orthopedic Physical Therapy Education
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04754568 |
|
Recruitment Status :
Completed
First Posted : February 15, 2021
Last Update Posted : September 21, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Virtual Reality | Other: Virtual reality instructional design Other: Role-playing instructional design | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 59 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | Virtual Reality Instructional Design in Orthopedic Physical Therapy Education: A Randomized Controlled Trial Comparing the Effects of Virtual Reality With Role-Playing Learning |
| Actual Study Start Date : | January 1, 2020 |
| Actual Primary Completion Date : | June 1, 2021 |
| Actual Study Completion Date : | August 1, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Virtual reality instructional design
Completion of virtual reality simulation of an outpatient physical therapy evaluation.
|
Other: Virtual reality instructional design
60 minute immersive VR experience with branching method information delivery, physical therapy assessment, and diagnosis. |
|
Active Comparator: Role-playing instructional design
Completion of traditional role-playing of a scripted outpatient physical therapy evaluation
|
Other: Role-playing instructional design
60 minute traditional role-playing with standardized patient |
- Change in clinical decision-making [ Time Frame: pre- and post-instructional design (immediately after completing virtual reality or role-playing) ]The Clinical Decision-Making Tool (CDM-Tool), a Likert-style questionnaire with 12 items, scored on a four-point scale. A higher raw score indicates a higher level of perceived decision-making ability.
- Change in metacognitive awareness [ Time Frame: pre and post-instructional design (immediately after completing virtual reality or role-playing) ]Metacognitive Awareness Inventory (MAI), a Likert-style questionnaire with 52-items, scored on a five-point scale. A higher raw score indicates a higher level of perceived metacognitive awareness.
- Self-reported measure of engagement [ Time Frame: Post-instruction (immediately after completing either virtual reality or role-playing experience) ]Six-item, five-point Likert-style instrument. A higher raw score indicates greater level of student engagement.
- Objective Structured Clinical Examination (OSCE) [ Time Frame: 1 week following allocated instruction (either virtual reality or role-playing) ]Practical examination with 2 cases, assessing a student's ability to generate hypotheses, perform tests or measures to rule-in or rule-out hypotheses, and deliver an appropriate intervention.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 22 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Students enrolled in their first year of physical therapy school at SU
Exclusion Criteria:
- Students enrolled in their second or third year of physical therapy school at SU
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04754568
| United States, Virginia | |
| Shenandoah University | |
| Winchester, Virginia, United States, 22601 | |
| Study Chair: | Patti Berg-Poppe, PT, PhD | University of South Dakota |
| Responsible Party: | Aaron Hartstein, Associate Professor, Shenandoah University |
| ClinicalTrials.gov Identifier: | NCT04754568 |
| Other Study ID Numbers: |
USD Paper 3 |
| First Posted: | February 15, 2021 Key Record Dates |
| Last Update Posted: | September 21, 2021 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

